Cellular and molecular determinants for the development of natural and induced regulatory T cells

Human Immunology

Volumn 73, Issue 8, 2012, Pages 773-782

  Yuan, Xiaomei ^a   Malek, Thomas R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RETINOIC ACID; STAT5 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

CELL LINEAGE; CELL MATURATION; CELL STIMULATION; CELLULAR IMMUNITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TH17 CELL; THYMOCYTE; TRANSCRIPTION REGULATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL LINEAGE; CYTOKINES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; LYMPHOCYTE ACTIVATION; MICE; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84864047819     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.05.010     Document Type: Review

References (147)

1. Fontenot J.D., Rasmussen J.P., Williams L.M., Dooley J.L., Farr A.G., Rudensky A.Y. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 2005, 22:329-341.
2. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance. regulatory T cell development and the forkhead family transcription factor Foxp3. Nat. Immunol. 2005, 6:331-337.
3. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 2001, 27:68-73.
4. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 2001, 27:20-21.
5. Chatila T.A., Blaeser F., Ho N., Lederman H.M., Voulgaropoulos C., Helms C., et al. JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 2000, 106. R75-81.
6. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 2001, 27:18-20.
7. + T regulatory cells. Nat. Immunol. 2003, 4:337-342.
8. Hori S., Nomura T., Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
9. + regulatory T cells. Nat. Immunol. 2003, 4:330-336.
10. Williams L.M., Rudensky A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 2007, 8:277-284.
11. Wan Y.Y., Flavell R.A. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 2007, 445:766-770.
12. Fontenot J.D., Dooley J.L., Farr A.G., Rudensky A.Y. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 2005, 202:901-906.
13. + regulatory T cells. Nat. Rev. Immunol. 2011, 11:119-130.
14. Lathrop S.K., Santacruz N.A., Pham D., Luo J., Hsieh C.S. Antigen-specific peripheral shaping of the natural regulatory T cell population. J. Exp. Med. 2008, 205:3105-3117.
15. + T cells. Immunity 2006, 25:249-259.
16. + T regulatory cells. J. Immunol. 2007, 178:4062-4071.
17. + T cells expressing the FoxP3 transcription factor. Immunity 2009, 30:899-911.
18. + subset. J. Immunol. 2009, 183:2261-2266.
19. Burchill M.A., Yang J., Vang K.B., Moon J.J., Chu H.H., Lio C.W., et al. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 2008, 28:112-121.
20. Lio C.W., Hsieh C.S. A two-step process for thymic regulatory T cell development. Immunity 2008, 28:100-111.
21. Kajiura F., Sun S., Nomura T., Izumi K., Ueno T., Bando Y., et al. NF-κB-inducing kinase establishes self-tolerance in a thymic stroma-dependent manner. J. Immunol. 2004, 172:2067-2075.
22. Akiyama T., Maeda S., Yamane S., Ogino K., Kasai M., Kajiura F., et al. Dependence of self-tolerance on TRAF6-directed development of thymic stroma. Science 2005, 308:248-251.
23. + immunoregulatory T cells. J. Exp. Med. 2001, 194:427-438.
24. Ribot J., Enault G., Pilipenko S., Huchenq A., Calise M., Hudrisier D., et al. Shaping of the autoreactive regulatory T cell repertoire by thymic cortical positive selection. J. Immunol. 2007, 179:6741-6748.
25. + T cells in the thymic cortex. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:11903-11908.
26. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 1999, 162:5317-5326.
27. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2001, 2:301-306.
28. Apostolou I., Sarukhan A., Klein L., von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 2002, 3:756-763.
29. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 2002, 168:4399-4405.
30. + T cell receptors. Immunity 2004, 21:267-277.
31. van Santen H.M., Benoist C., Mathis D. Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 2004, 200:1221-1230.
32. + T cells. J. Immunol. 2007, 178:7032-7041.
33. Hsieh C.S., Zheng Y., Liang Y., Fontenot J.D., Rudensky A.Y. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 2006, 7:401-410.
34. Bautista J.L., Lio C.W., Lathrop S.K., Forbush K., Liang Y., Luo J., et al. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 2009, 10:610-617.
35. + cells is limited to small clonal sizes. J. Exp. Med. 2009, 206:2121-2130.
36. Tai X., Cowan M., Feigenbaum L., Singer A. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat. Immunol. 2005, 6:152-162.
37. - cytokine responsive regulatory T cell precursors. J. Immunol. 2010, 184:6007-6013.
38. + immunoregulatory T cells that control autoimmune diabetes. Immunity 2000, 12:431-440.
39. Sadlack B., Merz H., Schorle H., Schimpl A., Feller A.C., Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993, 75:253-261.
40. Willerford D.M., Chen J., Ferry J.A., Davidson L., Ma A., Alt F.W. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995, 3:521-530.
41. Suzuki H., Kundig T.M., Furlonger C., Wakeham A., Timms E., Matsuyama T., et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995, 268:1472-1476.
42. + T cell numbers. J. Immunol. 2002, 169:4850-4860.
43. Malek T.R., Yu A., Vincek V., Scibelli P., Kong L. CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rβ-deficient mice. Implications for the nonredundant function of IL-2. Immunity 2002, 17:167-178.
44. Fontenot J.D., Rasmussen J.P., Gavin M.A., Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol. 2005, 6:1142-1151.
45. Barron L., Dooms H., Hoyer K.K., Kuswanto W., Hofmann J., O'Gorman W.E., et al. Cutting edge: mechanisms of IL-2-dependent maintenance of functional regulatory T cells. J. Immunol. 2010, 185:6426-6430.
46. + regulatory T cells. J. Immunol. 2007, 178:280-290.
47. + T regulatory cells. J. Immunol. 2008, 181:225-234.
48. + regulatory T cell development. J. Immunol. 2008, 181:3285-3290.
49. Malek T.R., Castro I. Interleukin-2 receptor signaling: at the interface between tolerance and immunity. Immunity 2010, 33:153-165.
50. Pandey A., Ozaki K., Baumann H., Levin S.D., Puel A., Farr A.G., et al. Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin. Nat. Immunol. 2000, 1:59-64.
51. Park L.S., Martin U., Garka K., Gliniak B., Di Santo J.P., Muller W., et al. Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor. J. Exp. Med. 2000, 192:659-670.
52. Mazzucchelli R., Hixon J.A., Spolski R., Chen X., Li W.Q., Hall V.L., et al. Development of regulatory T cells requires IL-7Rα stimulation by IL-7 or TSLP. Blood 2008, 112:3283-3292.
53. + regulatory T cells in human thymus. Nature 2005, 436:1181-1185.
54. + regulatory T cells in human thymus. J. Immunol. 2010, 184:2999-3007.
55. Shull M.M., Ormsby I., Kier A.B., Pawlowski S., Diebold R.J., Yin M., et al. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 1992, 359:693-699.
56. + regulatory T cells. J. Exp. Med. 2005, 201:1061-1067.
57. Marie J.C., Liggitt D., Rudensky A.Y. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-β receptor. Immunity 2006, 25:441-454.
58. Li M.O., Sanjabi S., Flavell R.A. Transforming growth factor-β controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 2006, 25:455-471.
59. + regulatory T cells. Nat. Immunol. 2008, 9:632-640.
60. Ouyang W., Beckett O., Ma Q., Li M.O. Transforming growth factor-β signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 2010, 32:642-653.
61. Sakaguchi N., Takahashi T., Hata H., Nomura T., Tagami T., Yamazaki S., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003, 426:454-460.
62. Tanaka S., Maeda S., Hashimoto M., Fujimori C., Ito Y., Teradaira S., et al. Graded attenuation of TCR signaling elicits distinct autoimmune diseases by altering thymic T cell selection and regulatory T cell function. J. Immunol. 2010, 185:2295-2305.
63. Fu G., Chen Y., Yu M., Podd A., Schuman J., He Y., et al. Phospholipase C{γ}1 is essential for T cell development, activation, and tolerance. J. Exp. Med. 2010, 207:309-318.
64. + regulatory T cells. J. Immunol. 2004, 172:5287-5296.
65. + Tregs. J. Clin. Invest. 2006, 116:2521-2531.
66. + cells. J. Exp. Med. 2008, 205:565-574.
67. Sauer S., Bruno L., Hertweck A., Finlay D., Leleu M., Spivakov M., et al. T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:7797-7802.
68. + regulatory T cells. Nat. Immunol. 2010, 11:618-627.
69. Ouyang W., Beckett O., Flavell R.A., Li M.O. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 2009, 30:358-371.
70. Kerdiles Y.M., Stone E.L., Beisner D.L., McGargill M.A., Ch'en I.L., Stockmann C., et al. Foxo transcription factors control regulatory T cell development and function. Immunity 2010, 33:890-904.
71. Gupta S., Manicassamy S., Vasu C., Kumar A., Shang W., Sun Z. Differential requirement of PKC-θ in the development and function of natural regulatory T cells. Mol. Immunol. 2008, 46:213-224.
72. Medoff B.D., Sandall B.P., Landry A., Nagahama K., Mizoguchi A., Luster A.D., et al. Differential requirement for CARMA1 in agonist-selected T-cell development. Eur. J. Immunol. 2009, 39:78-84.
73. + regulatory and natural killer-like T cells on signals leading to NF-κB activation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4566-4571.
74. Wan Y.Y., Chi H., Xie M., Schneider M.D., Flavell R.A. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function. Nat. Immunol. 2006, 7:851-858.
75. + regulatory T cells. J. Immunol. 2009, 182:6736-6743.
76. Barnes M.J., Krebs P., Harris N., Eidenschenk C., Gonzalez-Quintial R., Arnold C.N., et al. Commitment to the regulatory T cell lineage requires CARMA1 in the thymus but not in the periphery. PLoS Biol. 2009, 7:e51.
77. Long M., Park S.G., Strickland I., Hayden M.S., Ghosh S. Nuclear factor-κB modulates regulatory T cell development by directly regulating expression of Foxp3 transcription factor. Immunity 2009, 31:921-931.
78. Lee A.J., Wu X., Cheng H., Zhou X., Cheng X., Sun S.C. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling. J. Biol. Chem. 2010, 285:15696-15703.
79. + regulatory t cells is driven by the c-Rel enhanceosome. Immunity 2009, 31:932-940.
80. Zheng Y., Josefowicz S., Chaudhry A., Peng X.P., Forbush K., Rudensky A.Y. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 2010, 463:808-812.
81. Soligo M., Camperio C., Caristi S., Scotta C., Porto P.D., Costanzo A., et al. CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. Eur. J. Immunol. 2011.
82. Mantel P.Y., Ouaked N., Ruckert B., Karagiannidis C., Welz R., Blaser K., et al. Molecular mechanisms underlying FOXP3 induction in human T cells. J. Immunol. 2006, 176:3593-3602.
83. Malek T.R. The biology of interleukin-2. Annu. Rev. Immunol. 2008, 26:453-479.
84. Yao Z., Kanno Y., Kerenyi M., Stephens G., Durant L., Watford W.T., et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 2007, 109:4368-4375.
85. Yu A., Zhu L., Altman N.H., Malek T.R. A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. Immunity 2009, 30:204-217.
86. + T regulatory cells. J. Immunol. 2007, 178:4022-4026.
87. Apostolou I., von Boehmer H. In vivo instruction of suppressor commitment in naive T cells. J. Exp. Med. 2004, 199:1401-1408.
88. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M.C., von Boehmer H. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 2005, 6:1219-1227.
89. Mucida D., Kutchukhidze N., Erazo A., Russo M., Lafaille J.J. Curotto de Lafaille MA. Oral tolerance in the absence of naturally occurring Tregs. J. Clin. Invest. 2005, 115:1923-1933.
90. + regulatory T cells by peripheral expansion. J. Immunol. 2004, 173:7259-7268.
91. + regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 2005, 201:127-137.
92. Sun C.M., Hall J.A., Blank R.B., Bouladoux N., Oukka M., Mora J.R., et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. J. Exp. Med. 2007, 204:1775-1785.
93. Izcue A., Hue S., Buonocore S., Arancibia-Carcamo C.V., Ahern P.P., Iwakura Y., et al. Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis. Immunity 2008, 28:559-570.
94. Haribhai D., Lin W., Edwards B., Ziegelbauer J., Salzman N.H., Carlson M.R., et al. A central role for induced regulatory T cells in tolerance induction in experimental colitis. J. Immunol. 2009, 182:3461-3468.
95. Barnes M.J., Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity 2009, 31:401-411.
96. + regulatory T cells in the periphery of T cell receptor transgenic mice tolerized to transplants. J. Immunol. 2004, 172:6003-6010.
97. + T regulatory cells: role of tumor-derived TGF-β. J. Immunol. 2007, 178:2883-2892.
98. + regulatory T cell-dependent and -independent control of allergic inflammation. Immunity 2008, 29:114-126.
99. + regulatory T cell induction and expansion. J. Immunol. 2009, 183:4895-4903.
100. Gottschalk R.A., Corse E., Allison J.P. TCR ligand density and affinity determine peripheral induction of Foxp3 in vivo. J. Exp. Med. 2010, 207:1701-1711.
101. Delgoffe G.M., Kole T.P., Zheng Y., Zarek P.E., Matthews K.L., Xiao B., et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 2009, 30:832-844.
102. Harada Y., Elly C., Ying G., Paik J.H., DePinho R.A., Liu Y.C. Transcription factors Foxo3a and Foxo1 couple the E3 ligase Cbl-b to the induction of Foxp3 expression in induced regulatory T cells. J. Exp. Med. 2010, 207:1381-1391.
103. Guo F., Iclozan C., Suh W.K., Anasetti C., Yu X.Z. CD28 controls differentiation of regulatory T cells from naive CD4 T cells. J. Immunol. 2008, 181:2285-2291.
104. Kim J.M., Rudensky A. The role of the transcription factor Foxp3 in the development of regulatory T cells. Immunol. Rev. 2006, 212:86-98.
105. Benson M.J., Pino-Lagos K., Rosemblatt M., Noelle R.J. All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation. J. Exp. Med. 2007, 204:1765-1774.
106. Semple K., Nguyen A., Yu Y., Wang H., Anasetti C., Yu X.Z. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling. Blood 2011, 117:3096-3103.
107. + regulatory cells. J. Immunol. 2006, 176:3321-3329.
108. + regulatory T cells by TGF-β induction of transcription factor Foxp3. J. Exp. Med. 2003, 198:1875-1886.
109. - cells to develop suppressive activity: the role of IL-2, TGF-β, and IL-10. J. Immunol. 2004, 172:5213-5221.
110. Tone Y., Furuuchi K., Kojima Y., Tykocinski M.L., Greene M.I., Tone M. Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat. Immunol. 2008, 9:194-202.
111. Josefowicz S.Z., Wilson C.B., Rudensky A.Y. Cutting edge: TCR stimulation is sufficient for induction of Foxp3 expression in the absence of DNA methyltransferase 1. J. Immunol. 2009, 182:6648-6652.
112. Lu L., Wang J., Zhang F., Chai Y., Brand D., Wang X., et al. Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J. Immunol. 2010, 184:4295-4306.
113. + regulatory T cells in peripheral lymphoid organs of nonmanipulated mice. J. Exp. Med. 2010, 207:1393-1407.
114. + regulatory T cells and for expansion of these cells. J. Immunol. 2007, 178:2018-2027.
115. Mucida D., Park Y., Kim G., Turovskaya O., Scott I., Kronenberg M., et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science 2007, 317:256-260.
116. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 2007, 204:1757-1764.
117. + regulatory T cells. J. Immunol. 2008, 181:6923-6933.
118. Manicassamy S., Reizis B., Ravindran R., Nakaya H., Salazar-Gonzalez R.M., Wang Y.C., et al. Activation of β-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 2010, 329:849-853.
119. hi Cells. Immunity 2008, 29:758-770.
120. Mantel P.Y., Kuipers H., Boyman O., Rhyner C., Ouaked N., Ruckert B., et al. GATA3-driven Th2 responses inhibit TGF-β1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007, 5:e329.
121. Wang Y., Su M.A., Wan Y.Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 2011, 35:337-348.
122. + T cells. Clin. Exp. Immunol. 2008, 153:127-135.
123. Ivanov I.I. Frutos Rde L, Manel N, Yoshinaga K, Rifkin DB, Sartor RB, et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 2008, 4:337-349.
124. Atarashi K., Nishimura J., Shima T., Umesaki Y., Yamamoto M., Onoue M., et al. ATP drives lamina propria TH17 cell differentiation. Nature 2008, 455:808-812.
125. Atarashi K., Tanoue T., Shima T., Imaoka A., Kuwahara T., Momose Y., et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011, 331:337-341.
126. + regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12204-12209.
127. Hall J.A., Bouladoux N., Sun C.M., Wohlfert E.A., Blank R.B., Zhu Q., et al. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 2008, 29:637-649.
128. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
129. Mangan P.R., Harrington L.E., O'Quinn D.B., Helms W.S., Bullard D.C., Elson C.O., et al. Transforming growth factor-β induces development of the TH17 lineage. Nature 2006, 441:231-234.
130. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
131. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
132. Yang X.O., Nurieva R., Martinez G.J., Kang H.S., Chung Y., Pappu B.P., et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 2008, 29:44-56.
133. Zhou L., Ivanov I.I., Spolski R., Min R., Shenderov K., Egawa T., et al. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 2007, 8:967-974.
134. Zhou L., Lopes J.E., Chong M.M., Ivanov I.I., Min R., Victora G.D., et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nature 2008, 453:236-240.
135. Yang X.P., Ghoreschi K., Steward-Tharp S.M., Rodriguez-Canales J., Zhu J., Grainger J.R., et al. Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 2011, 12:247-254.
136. Maruyama T., Li J., Vaque J.P., Konkel J.E., Wang W., Zhang B., et al. Control of the differentiation of regulatory T cells and TH17 cells by the DNA-binding inhibitor Id3. Nat. Immunol. 2011, 12:86-95.
137. + T cells in gut Peyer's patches. Science 2009, 323:1488-1492.
138. + T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:1903-1908.
139. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martinez-Llordella M., Ashby M., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 2009, 10:1000-1007.
140. + Treg. Eur. J. Immunol. 2008, 38:912-915.
141. Rubtsov Y.P., Niec R.E., Josefowicz S., Li L., Darce J., Mathis D., et al. Stability of the regulatory T cell lineage in vivo. Science 2010, 329:1667-1671.
142. Rudra D., Egawa T., Chong M.M., Treuting P., Littman D.R., Rudensky A.Y. Runx-CBFβ complexes control expression of the transcription factor Foxp3 in regulatory T cells. Nat. Immunol. 2009, 10:1170-1177.
143. Floess S., Freyer J., Siewert C., Baron U., Olek S., Polansky J., et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol. 2007, 5:e38.
144. Polansky J.K., Kretschmer K., Freyer J., Floess S., Garbe A., Baron U., et al. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol. 2008, 38:1654-1663.
145. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
146. Lin W., Haribhai D., Relland L.M., Truong N., Carlson M.R., Williams C.B., et al. Regulatory T cell development in the absence of functional Foxp3. Nat. Immunol. 2007, 8:359-368.
147. + T regulatory cells. J. Immunol. 2010, 184:3433-3441.